Scott syndrome erythrocytes contain a membrane protein capable of mediating Ca2+-dependent transbilayer migration of membrane phospholipids

Journal of Clinical Investigation

Volumn 99, Issue 9, 1997, Pages 2232-2238

  Stout, James G ^a   Bassé, François ^a   Luhm, Robert A ^a   Weiss, Harvey J ^b   Wiedmer, Therese ^a   Sims, Peter J ^a  

^a BLOOD RESEARCH INSTITUTE   (United States)

^b Columbia Univ Coll Phys Surgs ^*  (United States)

Author keywords

blood coagulation; calcium; erythrocyte membrane; phosphatidylcholines; phosphatidylserines

Indexed keywords

CALCIUM ION; MEMBRANE PROTEIN; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLSERINE; PHOSPHOLIPID;

ARTICLE; BLEEDING DISORDER; CALCIUM CELL LEVEL; CELL TRANSPORT; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEFECT; ERYTHROCYTE MEMBRANE; HUMAN; HUMAN CELL; LIPID BILAYER; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SCOTT SYNDROME;

EID: 0031007981     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119397     Document Type: Article

References (37)

1. Schroit, A.J., and R.F.A. Zwaal. 1991. Transbilayer movement of phospholipids in red cell and platelet membranes. Biochim. Biophys. Acta. 1071:313-329.
2. Devaux, P. 1991. Static and dynamic lipid asymmetry in cell membranes. Biochemistry. 30:1163-1173.
3. Auland, M.E., B.D. Roufogalis, P.F. Devaux, and A. Zachowski. 1994. Reconstitution of ATP-dependent aminophospholipid translocation in proteoliposomes. Proc. Natl. Acad. Sci. USA. 91:10938-10942.
4. Connor, J., and A.J. Schroit. 1987. Determination of lipid asymmetry in human red cells by resonance energy transfer. Biochemistry. 26:5099-5105.
5. Tang, X.J., M.S. Halleck, R.A. Schlegel, and P. Williamson. 1996. A sub-family of P-type ATPases with aminophospholipid transporting activity. Science (Wash. DC). 272:1495-1497.
6. 2+ induces transbilayer redistribution of all major phospholipids in human crythrocytes. Biochemistry. 31:6355-6360.
7. Chang, C.-P., J. Zhao, T. Wiedmer, and P.J. Sims. 1993. Contribution of platelet microparticle formation and granule secretion to the transmembrane migration of phosphatidylserine. J. Biol. Chem. 268:7171-7178.
8. Smeets, E.F., P. Comfurius, E.M. Bevers, and R.F.A. Zwaal. 1994. Calcium-induced transbilayer scrambling of fluorescent phospholipid analogs in platelets and erythrocytes. Biochim. Biophys. Acta. 1195:281-286.
9. Bassé, F., P. Gaffet, F. Rendu, and A. Bienvenüe. 1993. Translocation of spin-labeled phospholipids through plasma membrane during thrombin- and ionophore A23187-induced platelet activation. Biochemistry. 32:2337-2344.
10. Bevers, E.M., P. Comfurius, and R.F. Zwaal. 1991. Platelet procoagulant activity: physiological significance and mechanisms of exposure. Blood Rev. 5:146-154.
11. Sims, P.J., E.M. Faioni, T. Wiedmer, and S.J. Shattil. 1988. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J. Biol. Chem. 263:18205-18212.
12. Wang, R.H., G. Phillips, Jr., M.E. Medof, and C. Mold. 1993. Activation of the alternative complement pathway by exposure of phosphatidylethanolamine and phosphatidylserine on erythrocytes from sickle cell disease patients. J. Clin. Invest. 92:1326-1335.
13. Fadok, V.A., D.R. Voelker, P.A. Campbell, J.J. Cohen, D.L. Bratton, and P.M. Henson. 1992. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148:2207-2216.
14. Williamson, P., E.M. Bevers, E.F. Smeets, P. Comfurius, R.A. Schlegel, and R.F.A. Zwaal. 1995. Continuous analysis of the mechanism of activated transbilayer lipid movement in platelets. Biochemistry. 34:10448-10455.
15. Bratton, D.L. 1994. Polyamine inhibition of transbilayer movement of plasma membrane phospholipids in the erythrocyte ghost. J. Biol. Chem. 269:22517-22523.
16. Gaffet, P., N. Bettache, and A. Bienvenüe. 1995. Transverse redistribution of phospholipids during human platelet activation: evidence for a vectorial outflux specific to aminophospholipids. Biochemistry. 34:6762-6769.
17. Comfurius, P., J.M. Senden, R.H. Tilly, A.J. Schroit, E.M. Bevers, and R.F. Zwaal. 1990. Loss of membrane phospholipid asymmetry in platelets and red cells may be associated with calcium-induced shedding of plasma membrane and inhibition of aminophospholipid translocasc. Biochim. Biophys. Acta. 1026:153-160.
18. Fox, J.E.B., C.C. Reynolds, and C.D. Austin. 1990. The role of calpain in stimulus-response coupling: Evidence that calpain mediates agonist-induced expression of procoagulant activity in platelets. Blood. 76:2510-2519.
19. 2+ and spermine on phosphatidylinositol 4,5-bisphosphate-mediated transmembrane redistribution of phospholipids in large unilamellar vesicles and in erythrocytes. Biochemistry. 35:13345-13352.
20. Sulpice, J.C., A. Zachowski, P.F. Devaux, and F. Giraud. 1994. Requirement for phosphatidylinositol 4,5-bisphosphate in the Ca(2+)-induced phospholipid redistribution in the human erythrocyte membrane. J. Biol. Chem. 269:6347-6354.
21. 2+-dependent transbilayer movement of phospholipid. J. Biol. Chem. 271:17205-17210.
22. Comfurius, P., P. Williamson, E.F. Smeets, R.A. Schlegel, E.M. Bevers, and R.F.A. Zwaal. 1996. Reconstitution of phospholipid scramblase activity from human blood platelets. Biochemistry. 35:7631-7634.
23. Weiss, H.J., W.J. Vicic, B.A. Lages, and J. Rogers. 1979. Isolated deficiency of platelet procoagulant activity. Am. J. Med. 67:206-213.
24. Weiss, H.J. 1994. Scott Syndrome: A disorder of platelet coagulant activity (PCA). Semin. Hematol. 31:312-319.
25. Sims, P.J., T. Wiedmer, C.T. Esmon, H.J. Weiss, and S.J. Shattil. 1989. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity. J. Biol. Chem. 264:17049-17057.
26. a binding sites on the platelets of a patient with a bleeding disorder. Blood. 54:1015-1022.
27. Ahmad, S.S., R. Rawala-Sheikh, B. Ashby, and P.N. Walsh. 1989. Platelet receptor-mediated factor X activation by factor IXa: high-affinity factor IXa receptors induced by factor VIII are deficient on platelets in Scott syndrome. J. Clin. Invest. 84:824-828.
28. Toti, F., N. Satta, E. Fressinaud, D. Meyer, and J.-M. Freyssinet. 1996. Scott syndrome, characterized by impaired transmembrane migration of procoagulant phosphatidylserine and hemorrhagic complications, is an inherited disorder. Blood. 87:1409-1415.
29. 2+-induced loss of phospholipid asymmetry in the human erythrocyte. A study in Scott Syndrome, a disorder of calcium-induced phospholipid scrambling. Blood. 86:1983-1991.
30. 2+-induced microvesiculation and deficient expression of procoagulant activity in erythrocytes from a patient with a bleeding disorder: a study of the red blood cells of Scott syndrome. Blood. 79:380-388.
31. Kojima, H., D. Newton-Nash, H.J. Weiss, P.J. Sims, and T. Wiedmer. 1994. Production and characterization of transformed B-lymphocytes expressing the membrane defect of Scott syndrome. J. clin. Invest. 94:2237-2243.
32. Steck, T.L., and J.A. Kant. 1974. Preparation of impermeable ghosts and inside-out vesicles from human erythrocyte membranes. Methods Enzymol. 31A:172-180.
33. Pomorski, T., A. Herrmann, A. Zachowski, P.F. Devaux, and P. Muller. 1994. Rapid determination of the transbilayer distribution of NBD-phospholipids in erythrocyte membranes with dithionite. Mol. Membr. Biol. 11:39-44.
34. McIntyre, J.C., and R.G. Sleight. 1991. Fluorescence assay for phospholipid membrane asymmetry. Biochemistry. 30:11819-11827.
35. Gorren, A.C., and J.A. Duine. 1994. The effects of pH and cations on the spectral and kinetic properties of methylamine dehydrogenase from Thiobacillus versutus. Biochemistry. 33:12202-12209.
36. 2+ requirement. J. Biol. Chem. 268:8999-9004.
37. 2+-ATPase inhibitors. Biochemistry. 34:11625-11634.